Potencial role of stem cell therapy in type 1 diabetes mellitus

FapUNIFESP (SciELO) - Tập 52 Số 2 - Trang 407-415 - 2008
Carlos Eduardo Barra Couri1, Júlio César Voltarelli1
1University of São Paulo, Brazil

Tóm tắt

Type 1 diabetes mellitus is the result of the autoimmune response against pancreatic beta-cell(s). At the time of clinical diagnosis near 70% of beta-cell mass is been destroyed as a consequence of the auto-destruction that begins months or even years before the clinical diagnosis. Although marked reduction of chronic complications was seen after development and progression of insulin therapy over the years for type 1 diabetic population, associated risks of chronic end-organ damage and hypoglycemia still remain. Besides tight glucose control, beta-cell mass preservation and/or increase are known to be other important targets in management of type 1 diabetes as long as it reduces chronic microvascular complications in the eyes, kidneys and nerves. Moreover, the larger the beta-cell mass, the lower the incidence of hypoglycemic events. In this article, we discuss some insights about beta-cell regeneration, the importance of regulation of the autoimmune process and what is being employed in human type 1 diabetes in regard to stem cell repertoire to promote regeneration and/or preservation of beta-cell mass.

Từ khóa


Tài liệu tham khảo

Notkins AL, 2001, Autoimmune type 1 diabetes: resolved and unresolved issues, J Clin Invest, 108, 1247, 10.1172/JCI14257

Gepts W, 1965, Pathologic anatomy of the pancreas in juvenile diabetes mellitus, Diabetes, 14, 619, 10.2337/diab.14.10.619

Matsumoto M, 1993, Transfer of autoimmune diabetes from diabetic NOD mice to NOD athymic nude mice: the roles of T-cell subsets in the pathogenesis, Cell Immunol, 148, 189, 10.1006/cimm.1993.1101

Li R, 2007, Bone Marrow Is a Preferential Homing Site for Autoreactive T-Cells in Type 1 Diabetes, Diabetes, 56, 2251, 10.2337/db07-0502

Pozzilli P, 2001, Autoimune diabetes not requiring insulin at diagnosis (latent autoimune diabetes of the adult), Diabetes Care, 24, 1460, 10.2337/diacare.24.8.1460

Petrone A, 2005, Residual insulin secretion at diagnosis of type 1 diabetes is independently associated with both, age of onset and HLA genotype, Diabetes Metab Res Rev, 21, 271, 10.1002/dmrr.549

Pozzilli P, 2001, IMDIAB Group: Is the process of beta-cell destruction in type 1 diabetes at time of diagnosis more extensive in females than in males?, Eur J Endocrinol, 145, 757, 10.1530/eje.0.1450757

Steele C, 2004, Insulin secretion in type 1 diabetes, Diabetes, 53, 426, 10.2337/diabetes.53.2.426

2002, The effect of intensive insulin therapy on the microvascular complications of type 1 diabetes mellitus, JAMA, 287, 2563, 10.1001/jama.287.19.2563

1998, The Diabetes Control and Complications Trial Research Group Effect of intensive therapy on residual beta-cell function in patients with type 1 diabetes in the Diabetes Control and Complications Trial, Ann Intern Med, 128, 517, 10.7326/0003-4819-128-7-199804010-00001

Swenne I, 1992, Pancreatic beta-cell growth and diabetes mellitus, Diabetologia, 35, 193, 10.1007/BF00400917

Fernandes A, 1997, Differentiation of new insulin-producing cells is induced by injury in adult pancreatic islets, Endocrinology, 138, 1750, 10.1210/endo.138.4.5049

Bonner-Weir S, 2002, Pancreatic stem cell, J Pathol, 197, 519, 10.1002/path.1158

Sako Y, 1990, Coupling of beta-cell desensitization by hyperglycemia to excessive stimulation and circulating insulin in glucose-infused rats, Diabetes, 39, 1580, 10.2337/diab.39.12.1580

Bernard C, 1999, Neogenesis vs. apoptosis as main components of pancreatic beta-cell as changes in glucose-infused normal and mildly diabetic adult rats, FASEB J, 13, 1195, 10.1096/fasebj.13.10.1195

Bonner-Weir S, 1989, Compensatory growth of pancreatic beta-cells in adult rats after short-term glucose infusion, Diabetes, 38, 49, 10.2337/diab.38.1.49

Topp BG, 2004, Metabolic adaptations to chronic glucose infusion in rats, Diabetologia, 47, 1602, 10.1007/s00125-004-1493-5

Bonner-Weir S, 1983, Partial pancreatectomy in the rat and subsequent defect in glucose-induced insulin release, J Clin Invest, 71, 1544, 10.1172/JCI110910

Menge BA, 2007, Partial pancreatectomy in adult humans does not provoke beta-cell regeneration, Diabetes

Kuroda A, 2003, beta-cell Regeneration in a Patient with Type 1 Diabetes Mellitus Who Was Receiving Immunosuppressive Therapy, Ann Intern Med, 139, 81, 10.7326/0003-4819-139-10-200311180-00030-w1

Burns CJ, 2004, Stem cell therapy for diabetes: do we need to make beta-cells?, J Endocrinol, 183, 437, 10.1677/joe.1.05981

Couri CE, 2006, Secondary prevention of type 1 diabetes mellitus: stopping immune destruction and promoting beta-cell regeneration, Braz J Med Biol Res, 39, 1271, 10.1590/S0100-879X2006001000002

Georgia S, 2004, beta-cell replication is the primary mechanism of maintaining postnatal beta-cell mass, J Clin Invest, 114, 963, 10.1172/JCI22098

Dor Y, 2004, Adult pancreatic beta-cells are formed by self-duplication rather than stem-cell differentiation, Nature, 429, 41, 10.1038/nature02520

Nir T, 2007, Recovery from diabetes in mice by beta cell regeneration, J Clin Invest, 117, 2559

Seaberg R, 2004, Clonal identification of multipotent precursors from adult mouse pancreas that generate neural and pancreatic lineages, Nat Biotechnol, 22, 1115, 10.1038/nbt1004

Bonner-Weir S, 2000, In vitro cultivation of human islets from expanded ductal tissue, Proc Natl Acad Sci USA, 97, 7999, 10.1073/pnas.97.14.7999

Jiang Y, 2002, Pluripotency of mesenchymal stem cells derived from adult bone marrow, Nature, 418, 41, 10.1038/nature00870

Chen LB, 2004, Differentiation of rat marrow mesenchymal stem cells into pancreatic islet beta-cells, World J Gastroenterol, 10, 3016, 10.3748/wjg.v10.i20.3016

Lee RH, 2006, Multipotent stromal cells from human marrow home to promote repair of pancreatic islets and renal glomeruli in diabetic NOD/scid mice, Proc Natl Acad Sci USA, 103, 17438, 10.1073/pnas.0608249103

Urbán VS, 2007, Mesenchymal Stem Cells Cooperate with Bone Marrow Cells in Therapy of Diabetes, Stem Cells

Lagasse E, 2000, Purified hematopoietic stem cell can differentiate into hepatocytes in vivo, Nat Med, 6, 1229, 10.1038/81326

Theise ND, 2000, Derivation of hepatocytes from bone marrow cells in mice after radiation-induced myeloablation, Hepatology, 31, 235, 10.1002/hep.510310135

Kang EM, 2005, Hematopoietic stem cell transplantation prevents diabetes in NOD mice but does not contribute to significant islet cell regeneration once disease is established, Exp Hematol, 33, 699, 10.1016/j.exphem.2005.03.008

Butler AE, 2007, Hematopoietic stem cells derived from adult donors are not a source of pancreatic-cells in adult nondiabetic humans, Diabetes, 56, 1810, 10.2337/db06-1385

Petersen BE, 1998, Hepatic oval cells express the hematopoietic stem cell marker Thy-1 in the rat, Hepatology, 27, 433, 10.1002/hep.510270218

Yang L, 2002, In vitro transdifferentiation of adult hepatic stem cells into pancreatic endocrine hormone-producing cells, Proc Natl Acad Sci USA, 99, 8078, 10.1073/pnas.122210699

Kim S, 2007, Streptozotocin-induced diabetes can be reversed by hepatic oval cell activation through hepatic transdifferentiation and pancreatic islet regeneration, Lab Invest, 87, 702, 10.1038/labinvest.3700561

Kodama S, 2003, Islet regeneration during the reversal of autoimmune diabetes in NOD mice, Science, 14, 1223, 10.1126/science.1088949

Chong AS, 2006, Reversal of diabetes in non-obese diabetic mice without spleen cell-derived beta-cell regeneration, Science, 311, 1774, 10.1126/science.1123510

Ende N, 2004, Effect of human umbilical cord blood cells on glycemia and insulitis in type 1 diabetic mice, Biochem Biophys Res Commun, 325, 665, 10.1016/j.bbrc.2004.10.091

Ende N, 2004, Transplantation of human umbilical cord blood cells improves glycemia and glomerular hypertrophy in type 2 diabetic mice, Biochem Biophys Res Commun, 321, 168, 10.1016/j.bbrc.2004.06.121

Naruse K, 2005, Therapeutic neovascularization using cord blood-derived endothelial progenitor cells for diabetic neuropathy, Diabetes, 54, 1823, 10.2337/diabetes.54.6.1823

Yang L, 2002, In vitro transdifferentiation of adult hepatic stem cells into pancreatic endocrine hormone-producing cells, Proc Natl Acad Sci USA, 99, 8078, 10.1073/pnas.122210699

Kim S, 2007, Streptozotocin-induced diabetes can be reversed by hepatic oval cell activation through hepatic transdifferentiation and pancreatic islet regeneration, Lab Invest, 87, 702, 10.1038/labinvest.3700561

Yatoh S, 2007, Differentiation of affinity-purified human pancreatic duct cells to beta-cells, Diabetes, 56, 1802, 10.2337/db06-1670

Le Blanc K, 2006, Mesenchymal stem cells: properties and role in clinical bone marrow transplantation, Curr Opin Immunol, 18, 586, 10.1016/j.coi.2006.07.004

Ryden M, 2003, Functional characterization of human mesenchymal stem cell-derived adipocytes, Biochem Biophys Res Commun, 311, 391, 10.1016/j.bbrc.2003.10.010

Assady S, 2001, Insulin production by human embryonic stem cells, Diabetes, 50, 1691, 10.2337/diabetes.50.8.1691

Hansson M, 2004, Artifactual insulin release from differentiated embryonic stem cells, Diabetes, 53, 2603, 10.2337/diabetes.53.10.2603

Hughes IA, 2004, A perspective on stem cells by a clinician, Eur J Endocrinol, 151, U3, 10.1530/eje.0.151U003

Byrne JA, 2007, Producing primate embryonic stem cells by somatic cell nuclear transfer, Nature, 450, 497, 10.1038/nature06357

Trucco M, 2005, Regeneration of the pancreatic beta-cell, J Clin Invest, 115, 5, 10.1172/JCI200523935

Voltarelli JC, 2007, Autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus, JAMA, 297, 1568, 10.1001/jama.297.14.1568

Burt RK, 2002, Induction of tolerance in autoimmune diseases by hematopoietic stem cell transplantation: Getting closer to a cure?, Blood, 99, 768, 10.1182/blood.V99.3.768

Haller MJ, 2007

Tuma-Mubarak J, 2007, Autologous bone marrow mononuclear cell (ABMMC) transplantation in type 1 and type 2 insulin-dependent diabetes mellitus patients, International Society of Cellular Therapy Meeting

Thông tin
Thông tin xuất bản

FapUNIFESP (SciELO)

Tập 52 Số 2

407-415

Thông tin tác giả